top of page



Jiangsu Hillgene established its headquarter (10000㎡ GMP plants and R&D Center) in Suzhou, located at Wuzhong District, Suzhou, a lakeshore city of the beautiful Taihu Lake, and two manufacturing sites in Shenzhen and Shanghai, basically extending its manufacturing site network to nationwide regions. The North Carolina Site in the US is currently under construction, with its presence further spreading globally. We have built an express pathway for the development of cellular therapy products from discovery to delivery, by establishing cellular therapy product specific platforms for nucleic acid manufacturing, serum-free suspension culturing, completely closed process development for cellular therapy products, and QC testing technology. Our platforms have supported lots of partners in the successful development of several CAR-T, TCR-T, and stem cell-based products. Hillgene is committed to bringing more products to the next milestone sooner and faster, facilitating the marketing of more cellular therapy products, thereby benefiting more patients, and writing a whole new chapter of life for cellular therapy products.

bottom of page